Helix Ventures

Helix Ventures, established in 2008, is a venture capital firm headquartered in Palo Alto, California. It specializes in healthcare investments, focusing on innovative therapeutic products that address significant patient needs and generate value for investors. The firm's partners, each with a blend of entrepreneurial, scientific, and investment experience, provide value-added support to management in building robust companies.

Graham Crooke

General Partner

Evgeny Zaytsev Ph.D

Co-Founder and General Partner

8 past transactions

Coherus Biosciences

Series C in 2014
Coherus Biosciences is a biopharmaceutical company focused on developing, manufacturing, and commercializing biologic therapeutics for oncology and inflammatory diseases. Its pipeline includes biosimilars for immunology, ophthalmology, and oncology.

Invuity

Series E in 2014
Invuity is a medical technology company that develops visualization products for minimally invasive and open surgeries. Using photonics technology, it directs and shapes light to provide broad, uniform illumination and direct visualization inside dark surgical cavities, enabling enhanced precision, efficiency, and safety. The product line includes illuminated retractors and handheld and intracavity illumination systems used in breast, orthopedic, spine, neurosurgery, endocrine, gynecologic, colorectal, and general procedures. Examples include Eikon LT and Eiberg illuminated retractors, PhotonBlade and PhotonSaber handheld illuminators, Breiten retractors, Photonguide XT intracavity illuminator, and PhotonVue visualization with indocyanine green imaging. Devices come in single-use and reusable formats and are sold directly to hospitals, surgeons, and to third-party manufacturers. Founded in 2004 and based in San Francisco, Invuity originated as Spotlight Surgical.

Coherus Biosciences

Debt Financing in 2013
Coherus Biosciences is a biopharmaceutical company focused on developing, manufacturing, and commercializing biologic therapeutics for oncology and inflammatory diseases. Its pipeline includes biosimilars for immunology, ophthalmology, and oncology.

iScience Interventional

Venture Round in 2012
iScience Interventional specializes in developing innovative medical technologies for ophthalmic interventions. They focus on creating advanced microcatheters and imaging systems, enabling eye specialists to precisely administer therapies to specific locations within the eye. Additionally, they offer medical devices for canaloplasty procedures.

Invuity

Venture Round in 2012
Invuity is a medical technology company that develops visualization products for minimally invasive and open surgeries. Using photonics technology, it directs and shapes light to provide broad, uniform illumination and direct visualization inside dark surgical cavities, enabling enhanced precision, efficiency, and safety. The product line includes illuminated retractors and handheld and intracavity illumination systems used in breast, orthopedic, spine, neurosurgery, endocrine, gynecologic, colorectal, and general procedures. Examples include Eikon LT and Eiberg illuminated retractors, PhotonBlade and PhotonSaber handheld illuminators, Breiten retractors, Photonguide XT intracavity illuminator, and PhotonVue visualization with indocyanine green imaging. Devices come in single-use and reusable formats and are sold directly to hospitals, surgeons, and to third-party manufacturers. Founded in 2004 and based in San Francisco, Invuity originated as Spotlight Surgical.

Coherus Biosciences

Series B in 2012
Coherus Biosciences is a biopharmaceutical company focused on developing, manufacturing, and commercializing biologic therapeutics for oncology and inflammatory diseases. Its pipeline includes biosimilars for immunology, ophthalmology, and oncology.

Coherus Biosciences

Series A in 2011
Coherus Biosciences is a biopharmaceutical company focused on developing, manufacturing, and commercializing biologic therapeutics for oncology and inflammatory diseases. Its pipeline includes biosimilars for immunology, ophthalmology, and oncology.

Invuity

Series C in 2010
Invuity is a medical technology company that develops visualization products for minimally invasive and open surgeries. Using photonics technology, it directs and shapes light to provide broad, uniform illumination and direct visualization inside dark surgical cavities, enabling enhanced precision, efficiency, and safety. The product line includes illuminated retractors and handheld and intracavity illumination systems used in breast, orthopedic, spine, neurosurgery, endocrine, gynecologic, colorectal, and general procedures. Examples include Eikon LT and Eiberg illuminated retractors, PhotonBlade and PhotonSaber handheld illuminators, Breiten retractors, Photonguide XT intracavity illuminator, and PhotonVue visualization with indocyanine green imaging. Devices come in single-use and reusable formats and are sold directly to hospitals, surgeons, and to third-party manufacturers. Founded in 2004 and based in San Francisco, Invuity originated as Spotlight Surgical.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.